Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Hye-Ri Kang"'
Autor:
Hye-Ri Kang, Monika Gjorgjieva, Stephanie N. Smith, Elizabeth D. Brooks, Zelin Chen, Shawn M. Burgess, Randy J. Chandler, Lauren R. Waskowicz, Kylie M. Grady, Songtao Li, Gilles Mithieux, Charles P. Venditti, Fabienne Rajas, Dwight D. Koeberl
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 15, Iss , Pp 383-391 (2019)
Glycogen storage disease type Ia (GSD Ia) is caused by mutations in the glucose-6-phosphatase (G6Pase) catalytic subunit gene (G6PC). GSD Ia complications include hepatocellular adenomas (HCA) with a risk for hepatocellular carcinoma (HCC) formation.
Externí odkaz:
https://doaj.org/article/b62c7d87ff05429b9ac33973aa0abe54
Autor:
Hye-Ri Kang, Lauren Waskowicz, Andrea M. Seifts, Dustin J. Landau, Sarah P. Young, Dwight D. Koeberl
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss , Pp 265-273 (2019)
Glycogen storage disease type Ia (GSD Ia) is a rare inherited disease caused by mutations in the glucose-6-phosphatase (G6Pase) catalytic subunit gene (G6PC). Absence of G6Pase causes life-threatening hypoglycemia and long-term complications because
Externí odkaz:
https://doaj.org/article/de679cdfd2184c5d826d0048eafe3c3b
Autor:
Woo-Chang Chung, Junsoo Kim, Byung Chul Kim, Hye-Ri Kang, JongHyeon Son, Hosam Ki, Kwang Yeon Hwang, Moon Jung Song
Publikováno v:
IUCrJ, Vol 5, Iss 6, Pp 866-879 (2018)
Poly(ADP-ribose) polymerase 1 (PARP-1), an enzyme that modifies nuclear proteins by poly(ADP-ribosyl)ation, regulates various cellular activities and restricts the lytic replication of oncogenic gammaherpesviruses by inhibiting the function of replic
Externí odkaz:
https://doaj.org/article/3001cd4ad9164bec9bbb8f93b5232938
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0200624 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0126456.].
Externí odkaz:
https://doaj.org/article/eeb58d8818d542deb5cc60db20c59c61
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0126456 (2015)
The inflammasome is a molecular platform that stimulates the activation of caspase-1 and the processing of pro-interleukin (IL)-1β and pro-IL-18 for secretion. The NOD-like receptor family, pyrin domain containing 3 (NLRP3) protein is activated by d
Externí odkaz:
https://doaj.org/article/fe116b0d0ef640ba95487c2018cf49f5
Autor:
Benjamin Arnson, Hye Ri Kang, Elizabeth D. Brooks, Dorothy Gheorghiu, Ekaterina Ilich, David Courtney, Jeffrey I. Everitt, Bryan R. Cullen, Dwight D. Koeberl
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 29, Iss , Pp 108-119 (2023)
Glycogen storage disease type Ia (GSD Ia) is the inherited deficiency of glucose-6-phosphatase (G6Pase), associated with life-threatening hypoglycemia and long-term complications, including hepatocellular carcinoma formation. Gene replacement therapy
Externí odkaz:
https://doaj.org/article/8282e120c0924cec897cf976a2665255
Autor:
Hayes Wong, Alexander W.M. Hooper, Hye Ri Kang, Shiron J. Lee, Jiayi Zhao, Chanchal Sadhu, Satinder Rawat, Steven J. Gray, David R. Hampson
Publikováno v:
JCI Insight, Vol 8, Iss 11 (2023)
Fragile X syndrome is a neurodevelopmental disorder caused by the absence of the mRNA-binding protein fragile X messenger ribonucleoprotein (FMRP). Because FMRP is a highly pleiotropic protein controlling the expression of hundreds of genes, viral ve
Externí odkaz:
https://doaj.org/article/7f55ad7e4b43445b8fa490f3c56b476a
Publikováno v:
Human gene therapy. 33(9-10)
Pompe disease is an autosomal recessive lysosomal storage disorder caused by deficiency of acid α-glucosidase (GAA), resulting in skeletal muscle weakness and cardiomyopathy. Muscle weakness progresses despite currently available therapy, which has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5122d23eee5dc0287a7f4566aaf81738
https://pubmed.ncbi.nlm.nih.gov/35102744
https://pubmed.ncbi.nlm.nih.gov/35102744
Autor:
Lauren R Waskowicz, Andrea M. Seifts, Dwight D. Koeberl, Sarah P. Young, Hye-Ri Kang, Dustin J. Landau
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss, Pp 265-273 (2019)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Glycogen storage disease type Ia (GSD Ia) is a rare inherited disease caused by mutations in the glucose-6-phosphatase (G6Pase) catalytic subunit gene (G6PC). Absence of G6Pase causes life-threatening hypoglycemia and long-term complications because
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5af7a959f893aea407a21c2f9343fd50
http://www.sciencedirect.com/science/article/pii/S2329050119300191
http://www.sciencedirect.com/science/article/pii/S2329050119300191
Publikováno v:
Biochemical and Biophysical Research Communications. 509:414-420
BST2 is an antiviral factor that inhibits the release of enveloped virus at the plasma membrane via an unusual topology in which its N-terminal is in the cytosol while its C-terminal is anchored by glycophosphatidylinositol (GPI). BST2-deficient cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::589153678e461242faf7ed07de95e718
https://doi.org/10.1016/j.bbrc.2018.12.110
https://doi.org/10.1016/j.bbrc.2018.12.110